ISLAMABAD
\nThe Competition Commission of Pakistan (CCP) and the Drug Regulatory Authority of Pakistan (DRAP) have signed a Memorandum of Understanding to enhance cooperation and strengthen oversight of Pakistan\u2019s pharmaceutical and therapeutic goods market through improved data and information sharing.
\nThe MoU was inked by Salman Amin, Member CCP, and Dr. Obaidullah, Chief Executive Officer DRAP. The ceremony held at CCP\u2019s head office was witnessed by Member CCP Saeed Ahmed Nawaz, Aamar Latif, Director Legal Affairs DRAP, and senior officials from both organizations.
\nThe MoU establishes a framework for closer coordination. Both institutions will share information, support joint enforcement, and strengthen monitoring of deceptive marketing practices, unfair competition, and misleading claims in the therapeutic goods and Over-the-Counter (OTC) categories.
\nThe agreement also covers digital data exchange, capacity building, and collaboration in research and policy analysis.
\nSpeaking at the ceremony, Member CCP Salman Amin said the partnership will ensure fair market practices which help economy and protect consumers.
\nThis collaboration is more imminent when online advertising and e-commerce have increased the risk of deceptive practices.
\nHe said that the pharmaceutical sector has a direct impact on public at large and both institutions have to work together to ensure transparency and fair competition.
\nDRAP CEO Dr. Obaidullah said federal regulatory bodies operate under defined mandates but share common goals in certain domains.
\nHe noted that price deregulation and supply challenges require coordinated oversight. He added that harmonization and collaboration between institutions improve regulatory outcomes and help maintain availability and fair pricing of essential medicines.
\nCCP and DRAP affirmed their commitment to implement the MoU through practical, joint actions that support consumer welfare and strengthen Pakistan\u2019s health-related markets.<\/p>\n","protected":false},"excerpt":{"rendered":"
ISLAMABAD The Competition Commission of Pakistan (CCP) and the Drug Regulatory Authority of Pakistan (DRAP) have signed a Memorandum of Understanding to enhance cooperation and strengthen oversight of Pakistan\u2019s pharmaceutical and therapeutic goods market through improved data and information sharing. The MoU was inked by Salman Amin, Member CCP, and Dr. Obaidullah, Chief Executive Officer […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":{"0":"post-517152","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business"},"yoast_head":"\n